logo
Can Alternative Cancer Treatments Work? Here's What Doctors Want You To Know

Can Alternative Cancer Treatments Work? Here's What Doctors Want You To Know

Yahoo12-06-2025
Ananda Lewis, the former video jockey who hosted MTV's 'Total Request Live' in the '90s, has died at the age of 52. Her sister, Lakshmi, posted a photo Wednesday of Ananda on Facebook alongside the caption, 'She's free, and in His heavenly arms.'
Though no further details have been shared regarding the cause of death, Lewis revealed in an Instagram post in 2020 that she had been diagnosed with breast cancer. The TV personality released another update last fall, letting fans know the cancer had metastasized after she opted against her physicians' recommendation to get a double mastectomy — a surgery that removes all breast tissue.
'They wanted to take both [breasts]. They wanted to do all of these big things that I was not ready for,' Lewis said in a roundtable discussion on CNN. Instead, she changed her diet, tweaked her sleep routine and made other lifestyle modifications in an effort to flush toxins out of her body. (It's been reported that later in her cancer journey, she underwent chemotherapy.)
Here's why so many people with cancer — like Lewis — opt for alternative treatments (like chiropractic medicine or herbal remedies) instead of radiation, chemotherapy or surgery. And how choosing an alternative path can affect your outcomes.
Lewis' decision is part of a popular trend in which more people are pursuing alternative treatments — like herbs, botanicals, vitamins and minerals, reiki and specialized diets — instead of traditional solutions like surgery, radiation and chemotherapy.
One report found that 48 to 88% of people with cancer use complementary treatments (complementary treatment refers to alternative treatments that are done in conjunction with conventional treatment). In fact, complementary and alternative medicine is now estimated to be a multibillion dollar industry in the United States.
Scientists suspect the recent surge in interest is due to a mix of factors. When it comes to medicine, people crave self-autonomy. People fighting cancer commonly feel like their doctors make all of the decisions, and some find that complementary and alternative therapies offer them a more hands-on role in their treatment and recovery, according to Cancer Research UK.
Dr. Cary Gross, founder and director of Yale School of Medicine's Cancer Outcomes Public Policy and Effectiveness Research Center, said some people are concerned about the side effects associated with chemotherapy. And the cost can be a huge deterrent, he added, as many procedures are 'ridiculously expensive.' Some people mistrust the medical establishment and doubt their providers have their best interests in mind when recommending treatment plans. Meanwhile, growing skepticism around science, in general, has influenced the type of treatment people pursue, Gross said.
Additionally, many alternative medicine providers and manufacturers have done an excellent job at marketing their products in a way that aligns with people's values and beliefs, evidence suggests. The advertising often falsely claims the treatments can effectively cure cancer or prolong your life, a study from 2023 found. The study's researchers, who scanned hundreds of online ads for alternative cancer care, stated that many of the brands 'exploited the hope of patients with terminal and poor prognoses by sharing testimonials of past patients who allegedly were cured or had their lives prolonged.'
Research shows that people who do alternative medicine and skip the evidence-backed treatments face a two to four times greater risk of death. This is largely due to the fact that those who go this route also tend to refuse conventional cancer treatments. Another study found that those who opt for alternative options die sooner than those who adhere to evidence-based solutions.
'Generally speaking, these alternative medicines have very little, if any, evidence to support their effectiveness against cancer,' Gross said. But it's not the ginkgo or the massage that will kill you. 'It's foregoing the actual treatment that causes harm.'
Breast cancer is very treatable if it's caught and treated early, said Dr. Karishma Kollipara, a breast surgeon with Northwell's Staten Island University Hospital. But if you decline surgery, for example, the cancer can spread — around the breast, to the lymph nodes and to other parts of the body. At that point, the treatment needed to cure the disease may be far more intensive, Kollipara said.
And at that point, people may need to add chemotherapy into their regimen. And the recommended surgery will likely be more invasive. In the earlier stages, surgery can be done to remove the cancer and nearby tissue in the breast, according to Kollipara. At later stages, the surgery is more invasive — people may need a mastectomy and potentially have some lymph nodes removed. 'The morbidity and mortality of everything increases as the cancer progresses,' she said.
This isn't to say there's no room for alternative medicine. In fact, research shows therapies like yoga, massage and acupuncture can improve people's quality of life when they're used alongside conventional treatments like chemotherapy. According to the National Cancer Institute, complementary therapies may help people cope with side effects such as pain, nausea and fatigue caused by conventional treatments. These treatments may also provide people with some peace of mind that they're doing all they can to treat or cure the disease, the agency added.
Gross says it's important to have a discussion with your care team if you're interested in complementary medicine. They can take a look at your medical history, the treatments you're taking, and help you weigh the risks and benefits. Occasionally, herbs can interact with chemotherapy, too, so they can let you know if there are any interactions to be aware of, he added.
Kollipara tells her patients that alternative therapies can sometimes be used in conjunction with traditional treatment. 'But it doesn't replace it,' she said. 'The thing that will cure the cancer is traditional treatment.'
All that said, Gross said, there's no right or wrong approach when it comes to fighting cancer. 'There is nothing wrong with saying, 'I do not want chemotherapy,'' he said.
His advice? Make sure you have all of the information at your fingertips. Then, make a decision that aligns with your goals, preferences and the facts. 'The patients are in the driver's seat,' he said.
Ananda Lewis, MTV VJ And Talk Show Host, Dies At 52
There's A Cancer Screening People In Their 30s Should Do That Can Dramatically Lower Your Risk Of Dying
New Study Finds 1 Promising Way To Keep Colon Cancer From Returning
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Americans spend less time reading for fun and more time on screens, study finds
Americans spend less time reading for fun and more time on screens, study finds

Yahoo

time40 minutes ago

  • Yahoo

Americans spend less time reading for fun and more time on screens, study finds

Fewer Americans are opening a book for fun each day, with reading for pleasure in the United States down 40% over the past 20 years, a new study finds. Researchers from University College London and the University of Florida analyzed surveys from more than 230,000 Americans aged 15 and older between 2003 and 2023, tracking their daily reading habits. Results, published in the journal iScience on Wednesday, showed the share of people who picked up a book, magazine or e-reader every day dropped about 3% per year. Reading with children was also rare, the study found, with only 2% of adults reporting doing so on average every day. MORE: How phonics is making a comeback as millions of kids struggle to read However, those who did read spent more time doing so, averaging more than 90 minutes daily. "For me, one of the most important takeaways of this study is awareness of how little reading for children is happening," Jill Sonke, one of the study's lead authors as well as director of research initiatives and a research professor at the University of Florida Center for Arts in Medicine, told ABC News. "As a mother, reading to my children was a really important time for bonding as well as for relaxation and for stimulating my children's interest in reading and their imagination and creativity." The study also found that reading declined more sharply among Black Americans, those with less education or lower incomes, and people in rural areas, with gaps widening over the 20-year study period. The researchers speculated that the drop is likely tied to the rise of digital media, including social platforms, streaming and online browsing. "There's a correlation between time spent on digital media and reductions in reading time," Sonke said. "It does seem logical that the ways in which digital media compete for our time would be a factor in these declines in reading." The auhtors cautioned that less reading could affect health, well-being and literacy. Reading has been linked to stronger language skills, reasoning and empathy, they said. "I think it's important for people to understand that reading for pleasure is actually a health promoting activity," Sonke said. "We know that participating in the arts is a health behavior because it statistically results in improved health outcomes including well-being, social cohesion, mental health." MORE: Many students have still not regained pandemic-era losses in reading, math: Report The study authors say that national strategies often focus mainly on children. The authors suggested that adult reading habits also deserve attention, especially given their impact on health and well-being. The National Literacy Trust, an independent charity based in London that promotes literacy, advises setting aside 10 minutes before bed, carrying a book or e-reader during commutes and making reading a shared family activity. Even small changes can help bring reading back into daily life, the group notes. Raihan El-Naas, MD is a board-certified internal nedicine physician and current endocrinology fellow at Weill Cornell Medical Center and Memorial Sloan Kettering Cancer Center and a member of the ABC News Medical Unit. Solve the daily Crossword

Nym Rated a Top Performer by KLAS in First Report Dedicated to Autonomous Medical Coding
Nym Rated a Top Performer by KLAS in First Report Dedicated to Autonomous Medical Coding

Yahoo

time40 minutes ago

  • Yahoo

Nym Rated a Top Performer by KLAS in First Report Dedicated to Autonomous Medical Coding

Report underscores autonomous coding's rapid adoption and Nym's role in delivering efficiency and scalability to healthcare provider organizations NEW YORK, August 20, 2025--(BUSINESS WIRE)--Nym, a leader in autonomous medical coding, has been rated by KLAS Research as a top performer in the first report dedicated to the autonomous coding market: "Autonomous Coding 2025: A Promising Start for an Early Market." The August 2025 report formally recognizes autonomous coding as a distinct and growing segment within healthcare technology and highlights the vendors driving measurable value for providers. Key Takeaways Nym's Overall Performance Score: 89.6 (based on evaluations from 12 unique Nym customers) Customer feedback highlights: High satisfaction with implementation and ongoing support, including onboarding and training processes that ensure a smooth go-live and ease user adoption Read the full report. KLAS's findings show that autonomous medical coding is gaining momentum, with the most significant adoption today in radiology and emergency department settings, areas where providers are realizing substantial efficiency and accuracy gains. Customers across the market are eager to extend autonomous coding to additional specialties, underscoring its potential to address coding-related staffing shortages and operational bottlenecks. Nym's performance in the report reflects its ability to deliver the outcomes healthcare organizations are prioritizing as they scale autonomous coding. By fully automating coding with no human intervention, Nym eliminates overtime costs and contract labor needs while ensuring charts are coded in seconds, helping providers accelerate payment cycles and reduce administrative burden. Customers in the report consistently credited Nym's thoughtful onboarding and training for enabling a smooth go-live, rapid user adoption, and sustained productivity gains; capabilities essential for long-term success. The report's customer perspectives bring these outcomes to life. "Nym's [autonomous medical coding engine] has completely transformed our ability to get through the volume of accounts. And one of our hospitals has a department that is one of the busiest in the country. I cut my need for human coders in half with this solution. And it was not that we eliminated all the positions. We just got rid of the overtime so our people can breathe now. We don't need to use contractors anymore, and we don't have open positions anymore. The solution has literally transformed our department. I cannot say enough good things about Nym." - Director, Autonomous Coding 2025: A Promising Start for an Early Market, August 2025. "KLAS's first report focused solely on autonomous coding marks a meaningful step forward for the industry," said Or Peles, CEO of Nym. "Nym's recognition as a top performer speaks to the progress we're making with providers today and the potential to deliver even greater value as adoption expands." Nym currently partners with over 25 healthcare organizations nationwide, including leading health systems, hospitals, and provider groups. About NymNym is the leader in transforming clinical language into actionable information, removing inefficiencies that add billions to the cost of care. By combining industry-leading technology with clinical expertise and a deep understanding of medical language, Nym accurately decodes medical charts in a way that is fast, explainable, and compliant. The Company's innovative autonomous medical coding solution translates provider notes into accurate diagnostic and billing codes in seconds, with zero human intervention and over 95% accuracy. Nym's solution delivers audit-ready documentation for every code it generates, ensuring complete visibility into coding decisions. Based in New York City with R&D capabilities in Tel Aviv, Nym is backed by leading investors including PSG, Addition, GV, Bessemer Venture Partners, Dynamic Loop Capital, and Tiger Global. Learn more at KLAS is a research and insights firm on a mission to improve healthcare delivery by amplifying the provider's voice. Working with thousands of healthcare professionals and clinicians, KLAS gathers data on software, services, and medical equipment to deliver timely reports and statistical overviews. Learn more at View source version on Contacts Media Contact Nicole Parisernicole@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Wisdom, the AI-Powered Dental Revenue Cycle Management Platform, Raises $28M to Accelerate Product Innovation and Capitalize on Rapid Growth
Wisdom, the AI-Powered Dental Revenue Cycle Management Platform, Raises $28M to Accelerate Product Innovation and Capitalize on Rapid Growth

Yahoo

time40 minutes ago

  • Yahoo

Wisdom, the AI-Powered Dental Revenue Cycle Management Platform, Raises $28M to Accelerate Product Innovation and Capitalize on Rapid Growth

SAN FRANCISCO, August 20, 2025--(BUSINESS WIRE)--AI in revenue cycle management has become top of mind across the healthcare industry, but when it comes to the dental market, dentists are lacking the modern tools used by their medical counterparts. That's the problem that AI-powered dental RCM platform, Wisdom, is on a mission to solve. The company announced today the successful completion of its $21M Series A capital raise led by Permanent Capital Ventures (PCV), a venture capital firm that partners with founders to build go-to-market engines for enterprise scale. Aquiline, a private investment firm specializing in financial services and technology, joined the round, alongside existing investor and Co-Founder, Juxtapose, a leading creation-oriented investment firm. Juxtapose followed their recent $7M Seed investment, reaffirming the firm's commitment to Wisdom's continued growth and innovation. This funding brings Wisdom's total capital raised to $28M since its founding in 2023. The overwhelming majority of independent practices and small dental groups in America struggle with the administrative burden of running a profitable business, leaving over $20 billion of earned revenue uncollected despite spending billions of dollars on salaries for in-house revenue management. Wisdom, which has already collected hundreds of millions of dollars for its clients and saved them up to 50% of collection costs, takes a highly differentiated approach to administrative workflows by bringing AI agents and human experts together to maximize revenue collections, predictability, transparency and patient satisfaction, thereby freeing dentists and their staff to focus on delivering outstanding patient care. Since its inception, Wisdom has rapidly expanded by combining advanced, proprietary AI-driven technology with US-based billing experts. This unique approach has propelled Wisdom to achieve exceptional client satisfaction, underscored by a consistently high Net Promoter Score of 73 and strong organic growth. Over 50% of Wisdom's signed deals still come through referrals. Wisdom was awarded Top Dental Billing Company by Healthcare Business Review earlier this year and was named a 2025 Dental Innovator Award winner by DentalIQ for its AI-assisted dental billing service. Wisdom is led by CEO Stoyan Kenderov, an accomplished technologist, product leader and executive with over 25 years of success building new products and transforming organizations into customer-obsessed teams that drive growth and profitability, most recently as COO of business payments platform Plastiq. Prior to his time at Plastiq, Stoyan held senior leadership roles at LendingClub, Intuit, Quicken, and many other international technology companies. Stoyan is joined by Wisdom Co-Founder and Chief Dental Billing Officer Ashley Bond, who previously founded and led the award-winning nationwide billing service, Bond Dental Billing. "We are thrilled to partner with PCV and Aquiline as we continue our mission to transform dental billing and revenue management," said Kenderov. "Their proactive approach and expertise in building scalable enterprises align perfectly with our vision to significantly enhance financial outcomes and operational efficiency for dental practices." PCV's investment in Wisdom reflects the firm's strategy of supporting innovative startups poised for transformational growth. "Wisdom has created an impressive track record by uniquely integrating AI technologies with deep industry expertise," said Mike Gamson, Co-Founder and Managing Partner at Permanent Capital Ventures. "We see immense potential in their ability to scale and redefine revenue management solutions in the dental sector and beyond." Aquiline has a history of building scaled revenue cycle management businesses, and this investment in Wisdom marks the firm's second investment supporting the dental industry. "While we continue to see significant innovation across dental, the market is filled with point solutions and generally lacks modern, end-to-end platforms, especially across the rev cycle process," said Dante La Ruffa, Partner at Aquiline. "We believe that Stoyan and his team are reimagining the future of dentistry, starting with the key pain points that have historically inhibited dentists from maximizing their time with patients." This funding will enable Wisdom to further enhance its technology platform, accelerate market expansion, and continue building out its exceptional team to better serve dental offices of all sizes - from private practices to multi-location dental groups across the country. "The opportunity to use technology to help dentists build and run their businesses more effectively is immense. Stoyan and his team have moved quickly but thoughtfully to build a solution which really moves the needle for dentists while preserving the value of human expertise," said Andy Stein, Partner at Juxtapose. For more information about Wisdom and its innovative dental billing solutions, please visit About Juxtapose Juxtapose is a creation-oriented investment firm building and funding industry-defining technology companies. Juxtapose's concept development and investment process is focused on multi-decade opportunities in complex industries that leverage the team's expertise in software and technology, human-centered design, commercial strategy, executive talent assessment, and private capital markets. Juxtapose has built and led the financing of companies across software, healthcare, and tech-enabled services that have raised over $1B of external, follow-on private capital. Founded in 2016, Juxtapose now has over $1B AUM. About Permanent Capital Ventures Permanent Capital Ventures is an expansion stage venture capital firm that partners with extraordinary founders building AI application businesses. We lean in with unique go-to-market expertise in the moments after product-market fit has been established to help unlock the path to enterprise scale. About Aquiline Aquiline Capital Partners LP ("Aquiline") is a private investment firm based in New York, London, and Philadelphia, that is dedicated to financial services and technology. As of June 30, 2025, Aquiline has approximately $13 billion of assets under management across the firm's three strategies in private equity, venture, and credit. Additional information is available on the firm's website: Aquiline Capital Partners LP ("Aquiline") is a private investment firm based in New York, London, and Philadelphia, that is dedicated to financial services and technology. As of June 30, 2025, Aquiline has approximately $13 billion of assets under management and has deployed approximately $7.4 billion of capital across the firm's three strategies in private equity, venture, and credit. View source version on Contacts Aquiline media contact:Charlie Cumiskey, Apella Advisors+44 (0)7958 964446, aquiline@ Wisdom Media contact:Brian Becker, Wisdombrian@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store